Skip to Content
MilliporeSigma
  • Changes in bone mineral density and metabolism in women: evaluation of bodily characteristics, bone metabolic markers and bone mineral density.

Changes in bone mineral density and metabolism in women: evaluation of bodily characteristics, bone metabolic markers and bone mineral density.

Hiroshima journal of medical sciences (2013-11-28)
Tadayuki Iida, Toshihide Harada, Fumiko Ishizaki, Yumiko Nitta, Satomi Aoi, Hiromi Ikeda, Chiho Chikamura, Mitsuhisa Shiokawa, Kohsaku Nitta
ABSTRACT

The relationship of bone mineral density (BMD) and bone metabolic markers in women is an interesting field of research. In this study, we aimed to clarify the relationship of body weight, bone metabolic markers and BMD. The subjects were 72 women. The levels of serum bone-specific alkaline phosphatase (BAP), serum type I collagen-cross-linked peptide (s-NTx) and urinary deoxypyridinoline (u-DPD) were measured. The associations between dependent variables (BMD changes/1 or 4 years in the lumbar spine and femoral neck) and explanatory variables (body weight changes/1 or 4 years, the levels of BAP, s-NTx, u-DPD) were evaluated using multiple regression analysis. Changes in the lumbar spine BMD were significantly correlated with changes in height over a year, and those of the femoral neck were significantly correlated with changes in weight over a year. Changes in the lumbar spine BMD over 4 years were significantly correlated with age, BAP and the changes of weight over 4 years. Changes in the femoral neck BMD over 4 years were significantly correlated with the changes in weight for 4 years. These results suggest that BMD changes of different bones correlate with different explanatory variables and that, to predict BMD changes from bone metabolic markers in women, it is necessary to measure BAP levels.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phosphatase, Alkaline bovine, recombinant, expressed in Pichia pastoris, ≥4000 units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline from Escherichia coli, buffered aqueous glycerol solution, 20-50 units/mg protein (in glycine buffer)
Sigma-Aldrich
Phosphatase, Alkaline from bovine intestinal mucosa, buffered aqueous solution, ≥2,000 DEA units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline from bovine intestinal mucosa, buffered aqueous glycerol solution, ≥4,000 DEA units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline from bovine intestinal mucosa, lyophilized powder, ≥10 DEA units/mg solid
Sigma-Aldrich
Phosphatase, Alkaline from Escherichia coli, lyophilized powder, 30-60 units/mg protein (in glycine buffer)
Sigma-Aldrich
Phosphatase, Alkaline from porcine kidney, lyophilized powder, ≥100 DEA units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline from Escherichia coli, ammonium sulfate suspension, 30-90 units/mg protein (modified Warburg-Christian, in glycine buffer)
Sigma-Aldrich
Phosphatase, Alkaline from bovine intestinal mucosa, ≥5,500 DEA units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline from bovine intestinal mucosa, BioUltra, ≥5,700 DEA units/mg protein
Sigma-Aldrich
Phosphatase, Alkaline shrimp, ≥900 DEA units/mL, buffered aqueous glycerol solution, recombinant, expressed in proprietary host